首页> 外文期刊>Journal of breath research >The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review
【24h】

The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review

机译:测量呼出的呼气生物标志物在结节病中的作用:系统评价

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Sarcoidosis is a chronic granulomatous disease of unknown aetiology with a variable clinical course and prognosis. There is a growing need to identify non-invasive biomarkers to differentiate between clinical phenotypes, identify those at risk of disease progression and monitor response to treatment. Objectives:Weundertook a systematic review and meta-analysis to evaluate the utility of breath-based biomarkers in discriminating sarcoidosis from healthy controls, alongside correlation with existing non breath-based biomarkers used in clinical practice, radiological stage, markers of disease activity and response to treatment. Methods: Electronic searches were undertaken during November 2017 using Pub Med, Ebsco, Embase and Web of Science to capture relevant studies evaluating breath-based biomarkers in adult patients with sarcoidosis. Results: 353 papers were screened; 21 met the inclusion criteria and assessed 25 different biomarkers alongside VOCs in exhaled breath gas or condensate. Considerable heterogeneity existed amongst the studies in terms of participant characteristics, sampling and analytical methods. Elevated biomarkers in sarcoidosis included 8-isoprostane, carbon monoxide, neopterin, TGF-β1, TNFα, CysLT and several metallic elements including chromium, silicon and nickel. Three studies exploring VOCs were able to distinguish sarcoidosis from controls. Meta-analysis of four studies assessing alveolar nitric oxide showed no significant difference between sarcoidosis and healthy controls (2.22 ppb; 95% CI-0.83, 5.27) however, a high degree of heterogeneity was observed with an I~2 of 93.4% (p < 0.001). Inconsistent or statistically insignificant results were observed for correlations between several biomarkers and radiological stage, markers of disease activity or treatment. Conclusions: The evidence for using breath biomarkers to diagnose and monitor sarcoidosis remains inconclusive with many studies limited by small sample sizes and lack
机译:简介:结节病是一种慢性肉芽肿疾病,具有可变的临床过程和预后。越来越需要鉴定非侵入性生物标志物以区分临床表型,确定有疾病进展的风险和监测对治疗的反应的那些。目的:Weundertook一个系统的评价和荟萃分析,以评估呼吸基生物标志物在临床实践中使用的现有非呼吸生物标志物,放射阶段,疾病活动标志物以及疾病活动标志物的相关性以及对疾病活动标志物的相关性治疗。方法:在2017年11月,使用PUB MED,EBSCO,EMBASE和科学网络进行了电子搜索,以捕获在成人患者中评估呼吸基生物标志物的相关研究。结果:筛选了353篇论文; 21符合纳入标准,并在呼出的呼吸气体或冷凝水中评估了25种不同的生物标志物。在参与者特征,抽样和分析方法方面存在相当大的异质性。结节病的升高的生物标志物包括8-异前列烷,一氧化碳,Neopterin,TGF-β1,TNFα,Cyslt和几种金属元素,包括铬,硅和镍。探索VOCs的三项研究能够区分从控制的吻合病。评估肺泡一氧化氮的四项研究的荟萃分析显示出牙垢病和健康对照(2.22ppb; 95%CI-0.83,5.27)之间没有显着差异,但是通过93.4%的I〜2观察到高度的异质性(p <0.001)。观察到几种生物标志物和放射阶段之间的相关性,疾病活动或治疗标记之间的相关性不一致或统计学微不足道的结果。结论:利用呼吸生物标志物诊断和监测结节病的证据仍然存在许多受小型样本尺寸和缺乏的研究

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号